Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × TIC10 compound × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other 1 Gynecologic 1

Conditions

Obesity 1 Neoplasm Metastasis 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Disease 1 Carcinosarcoma 1

Interventions

pembrolizumab 2 atezolizumab 1 TIC10 compound 1 Oncolytic Virotherapy 1 Observation 1 Interleukin-15 1 Biopsy 1 Antibodies, Monoclonal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting

GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡